Effect of melatonin on depressive symptoms and anxiety in patients undergoing breast cancer surgery: a randomized, double-blind, placebo-controlled trial

The effect of MELatOnin on Depression, anxietY, cognitive function and sleep disturbances in patients with breast cancer. The MELODY trial: protocol for a randomised, placebo-controlled, double-blinded trial

(2012) Melissa Voigt Hansen et al.   BMJ Open

Prevalence and Predictors of Sleep Difficulty in a National Cohort of Women With Primary Breast Cancer Three to Four Months Postsurgery

(2011) Ben Colagiuri et al.   JOURNAL OF PAIN AND SYMPTOM MANAGEMENT

Novel melatonin-based therapies: potential advances in the treatment of major depression

(2011) Ian B Hickie et al.   LANCET

Increasing prevalence of depression from 2000 to 2006

(2011) Ingelise Andersen et al.   SCANDINAVIAN JOURNAL OF PUBLIC HEALTH

A randomized double-blind placebo-controlled trial of treatment as usual plus exogenous slow-release melatonin (6 mg) or placebo for sleep disturbance and depressed mood

(2010) Marc Antony Serfaty et al.   INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY

Erratum: Agomelatine, the first melatonergic antidepressant: discovery, characterization and development

(2010) Christian de Bodinat et al.   NATURE REVIEWS DRUG DISCOVERY

Depression as a predictor of disease progression and mortality in cancer patients

(2009) Jillian R. Satin et al.   CANCER

Antidepressant-like effects of melatonin in the mouse chronic mild stress model

(2009) Bernardo C. Detanico et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

Bidirectional communication between sleep and circadian rhythms and its implications for depression: Lessons from agomelatine

(2009) Seithikurippu R. Pandi-Perumal et al.   PROGRESS IN NEUROBIOLOGY

Antidepressant action of melatonin in the treatment of Delayed Sleep Phase Syndrome

(2009) Shadab A. Rahman et al.   SLEEP MEDICINE

Major depression after breast cancer: a review of epidemiology and treatment

(2008) Jesse R. Fann et al.   GENERAL HOSPITAL PSYCHIATRY